These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Development of a transgenic mouse model for carcinogenesis bioassays: evaluation of chemically induced skin tumors in Tg.AC mice. Spalding JW; French JE; Tice RR; Furedi-Machacek M; Haseman JK; Tennant RW Toxicol Sci; 1999 Jun; 49(2):241-54. PubMed ID: 10416269 [TBL] [Abstract][Full Text] [Related]
8. Tripropylene glycol diacrylate but not ethyl acrylate induces skin tumors in a twenty-week short-term tumorigenesis study in Tg.AC (v-Ha-ras) mice. Nylander-French LA; French JE Toxicol Pathol; 1998; 26(4):476-83. PubMed ID: 9715506 [TBL] [Abstract][Full Text] [Related]
9. Chemically induced skin carcinogenesis in a transgenic mouse line (TG.AC) carrying a v-Ha-ras gene. Spalding JW; Momma J; Elwell MR; Tennant RW Carcinogenesis; 1993 Jul; 14(7):1335-41. PubMed ID: 8330346 [TBL] [Abstract][Full Text] [Related]
10. Hemizygous Tg.AC transgenic mouse as a potential alternative to the two-year mouse carcinogenicity bioassay: evaluation of husbandry and housing factors. Holden HE; Stoll RE; Spalding JW; Tennant RW J Appl Toxicol; 1998; 18(1):19-24. PubMed ID: 9526830 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Tg.AC transgenic mouse assay for testing the human carcinogenic potential of pharmaceuticals--practical pointers, mechanistic clues, and new questions. Sistare FD; Thompson KL; Honchel R; DeGeorge J Int J Toxicol; 2002; 21(1):65-79. PubMed ID: 11936901 [TBL] [Abstract][Full Text] [Related]
12. Topical application of representative multifunctional acrylates produced proliferative and inflammatory lesions in F344/N rats and B6C3F1 mice, and squamous cell neoplasms in Tg.AC mice. Doi AM; Hailey JR; Hejtmancik M; Toft JD; Vallant M; Chhabra RS Toxicol Pathol; 2005; 33(6):631-40. PubMed ID: 16176922 [TBL] [Abstract][Full Text] [Related]
13. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin. Owens DM; Spalding JW; Tennant RW; Smart RC Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738 [TBL] [Abstract][Full Text] [Related]
14. A transgenic mouse model (TG.AC) for skin carcinogenesis: inducible transgene expression as a second critical event. Hansen LA; Spalding JW; French JE; Tennant RW Prog Clin Biol Res; 1995; 391():223-35. PubMed ID: 8532720 [TBL] [Abstract][Full Text] [Related]
18. Association of tumor development with increased cellular proliferation and transgene overexpression, but not c-Ha-ras mutations, in v-Ha-ras transgenic Tg.AC mice. Hansen LA; Trempus CS; Mahler JF; Tennant RW Carcinogenesis; 1996 Sep; 17(9):1825-33. PubMed ID: 8824502 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Tg.AC assay: specificity testing with three noncarcinogenic pharmaceuticals that induce selected stress gene promoters in vitro and the inhibitory effects of solvent components. Thompson KL; Rosenzweig BA; Weaver JL; Zhang J; Lin KK; Sistare FD Toxicol Sci; 2003 Aug; 74(2):271-8. PubMed ID: 12773758 [TBL] [Abstract][Full Text] [Related]
20. Dermal carcinogenicity in transgenic mice: relative responsiveness of male and female hemizygous and homozygous Tg.AC mice to 12-O-tetradecanoylphorbol 13-acetate (TPA) and benzene. Blanchard KT; Ball DJ; Holden HE; Furst SM; Stoltz JH; Stoll RE Toxicol Pathol; 1998; 26(4):541-7. PubMed ID: 9715513 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]